Palifermin Withdrawn Phase 2 Trials for Chronic Myeloid Leukemia (CML) / Osteomyelofibrosis / Myelodysplastic Syndrome / Leukemia, Acute / Non-Hodgkin's Lymphoma (NHL) Treatment